Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
05/2010
05/20/2010WO2010056099A1 Cell regeneration compound
05/20/2010WO2010055929A1 Novel hsp90-targeted anti-cancer chimeric peptide
05/20/2010WO2010054575A1 Acenaphtho heterocycle compounds, cyclodextrin inclusion compounds and complexes, and uses in the manufactures of bh3 protein analogue, bcl-2 family protein inhibitors thereof
05/20/2010WO2009102433A3 Compounds with mdr1-inverse activity
05/20/2010US20100125101 Immunostimulatory nucleic acid molecules
05/20/2010US20100125100 GOLD NANOROD-siRNA COMPLEXES AND METHODS OF USING SAME
05/20/2010US20100125075 Antibacterial Agents
05/20/2010US20100125070 Bupropion Metabolites and Methods of Their Synthesis and Use
05/20/2010US20100124543 Sulphonamide derivatives as prodrugs of aspartyl protease inhibitors
05/20/2010CA2743709A1 Treatment of proteinopathies using a farnesyl transferase inhibitor
05/20/2010CA2742856A1 Acenaphtho heterocycle compounds, cyclodextrin inclusion compounds and complexes, and uses in the manufactures of bh3 protein analogue, bcl-2 family protein inhibitors thereof
05/19/2010EP2186818A1 Chemical synthesis of phosphatidylinositol mannoside glycans form mycobacterium tuberculosis
05/19/2010EP2186803A2 Substituted thioacetamides
05/19/2010EP2186792A1 2-(a-hydroxypentyl) benzoate and its preparation and use
05/19/2010EP2186530A1 Promoters exhibiting endothelial cell specificity and methods of using same
05/19/2010EP2186524A1 Use of hepcidin for preparing a medicament for treating disorders of iron homeostasis
05/19/2010EP2186523A1 Use of escin for treatment of Type IV hypersensitivity reaction
05/19/2010EP2186513A1 Use of specific cyclolignans
05/19/2010EP2185187A1 Subcutaneous administration of alpha-galatosidase a
05/19/2010EP2185156A1 Treatments and prevention of hydrocephalus
05/19/2010EP1467995B1 Pyrrolopyrimidine a2b selective antagonist compounds, their synthesis and use
05/19/2010EP1463487B1 Liposomal delivery of vitamin e based compounds
05/19/2010EP1371646B1 Aryl-substituted alicyclic compound and medical composition comprising the same
05/19/2010EP1368060B1 Hmgb1 protein inhibitors and/or antagonists for the treatment of vascular diseases
05/19/2010EP0888374B1 HIGH AFFINITY NUCLEIC ACID LIGANDS OF THE COMPLEMENT SYSTEM PROTEIN C1q
05/19/2010CN1994420B Blood-clearing face-beautifying health product and preparation method thereof
05/19/2010CN1943332B Method for producing super fine silk yarn
05/19/2010CN101711162A Processed product of fenugreek seed, and method for production thereof
05/19/2010CN101708242A Traditional Chinese medicine prescription for preventing and treating spleen necrosis syndrome of meaty ducks
05/19/2010CN101156888B A traditional Chinese medicine for treating appendicitis
05/19/2010CN101129826B Health pillow with Chinese medicine
05/19/2010CN101108241B Medicament for improving pigling survival rate and method of manufacturing the same
05/19/2010CN101095673B Application of 3-benzyl-5-(2-nitrophenoxymethyl)-gamma-butyrolactone
05/19/2010CN101066319B Chinese medicine composition for treating flaccidity syndrome
05/19/2010CN101044884B Method for prepairng feed additives containing yolk anti body
05/19/2010CN101028077B Method for preparing cactus nutrient dried brown rice vermicelli
05/19/2010CN101023968B Coenzyme composition preparing method
05/19/2010CN101011176B Healthy drink for reinforcing stomach and building a healthy body and production method thereof
05/19/2010CN101011118B Infant nutrient honey and processing method thereof
05/19/2010CN101006863B A granular health product of panax natoginseng
05/19/2010CN101002903B Oral traditional Chinese medicine for treat upper-energizer damp-heat type night sweat disease
05/19/2010CN101002902B Oral traditional Chinese medicine for treating middle-energizer damp-heat type night sweat disease
05/19/2010CN101002872B Oral traditional Chinese medicine for treating anemic hemidrosis
05/18/2010USRE41339 N-acetyl aldosamines, N-acetylamino acids and related N-acetyl compounds and their topical use
05/18/2010US7718795 Succinoylamino benzodiazepines as inhibitors of aβ protein production
05/18/2010US7718776 Comprises monoclonal antibody which specifically binds osteoprotegerin ligand (OPGL) for diagnosis, prevention and treatment of bone disorders
05/18/2010US7718705 administering on an as-needed basis to the mammal a therapeutically effective amount of dapoxetin or salt to a male human to treat sexual dysfunction e.g. premature ejaculation
05/18/2010US7718645 4-[4-(4-Amino-5-oxo-7,8-dihydropyrimido[5,4-f][1,4]oxazepin-6(5H)-yl)phenyl]cycloalkylalkyl nitriles, carboxy acids or esters, amides, e.g., a -cyclohexylacetonitrile; diglyceride acyltransferase inhibitors for treating type II diabetes and obesity
05/18/2010US7718643 Pharmaceutical formulation
05/18/2010US7718636 Administering to a post menopausal woman an effective amount of 2-methylene -19-nor-20(S)-1 alpha ,25-dihydroxyvitamin D3
05/18/2010US7718623 Immunostimulatory oligonucleotide that induces interferon alpha
05/18/2010US7718617 Using tissue preservation solution ( kallikrein inhibitor ) to decrease reperfusion injury of an organ during surgery and/or following removal of organ
05/18/2010US7718606 Methods for treating muscle diseases and disorders
05/18/2010US7718376 Identification and isolation of somatic stem cells and uses thereof
05/18/2010US7718200 Plant extract mixtures and their uses
05/18/2010US7718192 Tamper-resistant oral opioid agonist formulations
05/18/2010US7718177 Antibodies directed to fragments of connective tissue growth factor (CTGF) polypeptide and methods and uses thereof
05/18/2010CA2557882C Defective packaging non-oncoviral vectors based on mpmv and hiv
05/18/2010CA2473205C Orodispersible pharmaceutical composition comprising perindopril
05/18/2010CA2465247C Benzimidazoles and analogues and their use as protein kinases inhibitors
05/18/2010CA2437754C Tablets quickly disintegrated in oral cavity
05/18/2010CA2422371C Pyrazole compounds useful as protein kinase inhibitors
05/18/2010CA2422367C Pyrazole compounds useful as protein kinase inhibitors
05/18/2010CA2382465C Compositions and methods for modulating apoptosis in cells over-expressing bcl-2 family member proteins
05/18/2010CA2355716C Benzisoxazoles and phenones as .alpha.2-antagonists
05/18/2010CA2304204C Quinoline-containing .alpha.-ketoamide cysteine and serine protease inhibitors
05/18/2010CA2288709C Oxalate-degrading microorganisms or oxalate-degrading enzymes for preventing oxalate related disease
05/18/2010CA2266429C Hedgehog interacting proteins and uses related thereto
05/18/2010CA2259143C G-beta-gamma regulated phosphatidylinositol-3' kinase p101 regulatory subunit
05/14/2010WO2010053606A2 Small-molecule inhibitors of protein synthesis inactivating toxins
05/14/2010WO2010053127A1 MODULATOR OF α1GABAA RECEPTOR OR α5GABAA RECEPTOR
05/14/2010WO2010053101A1 Eye drop having high intraocular migration properties, fluorescent imaging agent, and methods for producing same
05/14/2010WO2010053085A1 Agent for preventing acidosis in ruminant animals
05/14/2010WO2010053068A1 Novel useful therapeutic agent for lower urinary tract symptom
05/14/2010WO2010052836A1 Aqueous solution of antimicrobial agent and method for producing same
05/14/2010WO2010052814A1 Composition for hard tissue regenerative therapy
05/14/2010WO2010052625A1 Pyrrolidines
05/14/2010WO2010051961A1 Chemical synthesis of phosphatidylinositol mannoside glycans from mycobacterium tuberculosis
05/14/2010WO2010008519A3 In vitro diagnostic markers comprising carbon nanoparticles and kits
05/14/2010CA2741589A1 Pyrrolidines
05/13/2010US20100122357 Human albumin animal models for drug evaluation, toxicology and immunogenicity studies
05/13/2010US20100121039 Methods and compositions for prolonging elimination half-times of bioactive compounds
05/13/2010US20100120922 Liquid formulations containing a carotinoid
05/13/2010US20100120914 Medicament for prophylactic and/or therapeutic treatment of hepatic steatosis or non-alcoholic steatohepatitis
05/13/2010US20100120910 Cosmetic Compositions Comprising Esters Based on 2-Propylheptanol
05/13/2010US20100120909 Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof
05/13/2010US20100120901 Novel compounds, pharmaceutical compositions containing same, and methods of use for same
05/13/2010US20100120893 Compositions and Methods for Inhibiting Expression of Transthyretin
05/13/2010US20100120875 Use of 4-[(4-thiazolyl)phenoxy]alkoxy-benzamidine derivatives for treatment of osteoporosis
05/13/2010US20100120804 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
05/13/2010US20100120802 Novel Anti-Inflammatory and Analgesic Heterocyclic Amidines that Inhibit Nitrogen Oxide (NO) Production
05/13/2010US20100120800 Agent for preventing recurrence of cerebrovascular disorder and agent for ameliorating troubles following cerebrovascular disorder and inhibiting progress thereof
05/13/2010US20100120736 Mineralocorticoid Receptor Antagonists
05/13/2010US20100120734 Formoterol/steroid bronchodilating compositions and methods of use thereof
05/13/2010US20100120725 Substituted Phenylsulfonamide Inhibitors of Beta Amyloid Production
05/13/2010US20100120720 Use of hmg-coa reductase and farnesyl-pyrophosphate synthase inhibitors for the preparation of a medicine
05/13/2010US20100120704 Cardiac glycosides to treat cystic fibrosis and other IL-8 dependent disorders
05/13/2010US20100120693 Medicament for improving prognostic survival in therapy of malignant tumor
05/13/2010US20100120674 Insulin resistance improving agents
05/13/2010US20100120143 Induction of apoptosis and cell growth inhibition by protein 4.33
1 ... 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 ... 1564